Evolution of bone mineral density in AIDS patients on treatment with zidovudine/lamivudine plus abacavir or lopinavir/ritonavir.
about
Vitamin D and Osteoporosis in HIV/HCV Coinfected Patients: A Literature ReviewProspective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz.Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen.Fracture incidence in HIV-infected women: results from the Women's Interagency HIV Study.Effects of HIV infection and antiretroviral therapy with ritonavir on induction of osteoclast-like cells in postmenopausal womenIncreased bone resorption during tenofovir plus lopinavir/ritonavir therapy in Chinese individuals with HIVAntiretroviral therapy in Indian setting: when & what to start with, when & what to switch to?HIV and bone metabolismFractures after antiretroviral initiation.Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system.WNT/beta-catenin signaling is involved in regulation of osteoclast differentiation by human immunodeficiency virus protease inhibitor ritonavir: relationship to human immunodeficiency virus-linked bone mineral lossThe Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis.Continuous antiretroviral therapy decreases bone mineral density.Bone mineral density effects of randomized regimen and nucleoside reverse transcriptase inhibitor selection from ACTG A5142.Role of bone mineral density in predicting morphometric vertebral fractures in patients with HIV infection.Is vitamin D deficiency involved in the immune reconstitution inflammatory syndrome?Bone mineral density in people living with HIV: a narrative review of the literature.Disrupted trabecular bone micro-architecture in middle-aged male HIV-infected treated patients.Bone mineral density changes after 2 years of ARV treatment, compared to naive HIV-1-infected patients not on HAART.Evaluation of bone alterations in the jaws of HIV-infected menopausal women.Switch from tenofovir disoproxil fumarate combination to dolutegravir with rilpivirine improves parameters of bone health.The Aging Skeleton: Differences Between HIV-Infected Patients and the Uninfected Aging Population
P2860
Q26798289-440BE4A6-E3E5-4FDD-AC6C-B27F96FAF6C4Q34158739-8528B355-2BC2-41C9-8169-577DECA006B8Q34403352-5FE7304B-2982-435F-8762-6A97B0D7F661Q35024409-C8E3F064-5D48-4DDC-A8C0-9BF25B902F8BQ35055196-2101785D-4407-404C-B6F6-175EC845081BQ35102114-39C94FE8-55E9-43BE-A320-91F6DEF732DAQ35770848-B62FE427-E803-4322-9849-B80C3AC72AC9Q36671233-3333BEDB-C76A-41CB-A4A0-C4C452D68509Q36839748-65EA8964-C646-4C14-9919-23A8B61CC78CQ36938343-7A4FCC7B-0001-4015-BEFD-AE4849294BB0Q37073777-FE478316-4601-4133-889F-0DAD81BCD3E8Q37287589-CDED017F-4A86-42C2-A83A-134C10D5E29BQ37357149-2E6ACAF5-9AA2-412A-B18F-CE5B880B9CEAQ37641866-EF6D94CF-D56C-4DA6-8A25-8B7A15E45FE0Q38435884-6F1CBB15-0B49-4E86-87AE-F94753A46E58Q38951653-FAB38E83-B39C-4CDF-AEC1-F46171BB4D58Q40107245-E65357B6-243F-4028-9925-3472B56A4B26Q40671853-F63B044F-F441-442B-ACD8-74CE93348866Q41647237-D41494B4-1015-417F-B978-33CCF9E3EB41Q44612029-BFA45002-E8AC-4385-ABEC-6E29B3BBB611Q49564927-F741EC73-A4DB-412E-97CC-3834A8458F62Q58797971-87A62120-C635-4115-8D2D-BC8A09FDB87C
P2860
Evolution of bone mineral density in AIDS patients on treatment with zidovudine/lamivudine plus abacavir or lopinavir/ritonavir.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Evolution of bone mineral dens ...... acavir or lopinavir/ritonavir.
@en
Evolution of bone mineral dens ...... acavir or lopinavir/ritonavir.
@nl
type
label
Evolution of bone mineral dens ...... acavir or lopinavir/ritonavir.
@en
Evolution of bone mineral dens ...... acavir or lopinavir/ritonavir.
@nl
prefLabel
Evolution of bone mineral dens ...... acavir or lopinavir/ritonavir.
@en
Evolution of bone mineral dens ...... acavir or lopinavir/ritonavir.
@nl
P2093
P2860
P1433
P1476
Evolution of bone mineral dens ...... acavir or lopinavir/ritonavir.
@en
P2093
A Goyenechea
M Díaz-Curiel
M Górgolas
M L Fernández-Guerrero
R García-Delgado
P2860
P356
10.1111/J.1468-1293.2007.00525.X
P577
2007-12-18T00:00:00Z